Back to search
FDAFDA · Food and drugs·Recall number D-0828-2022

NAD+ Nicotinamide Adenine Dinucleotide Lyophilized powder for reconstitution, Multi-Dose 500 mg Per Vial, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0083-00

Published May 4, 2022 · Recall initiated: April 4, 2022

Summary

FDA records drug Class II recall D-0828-2022, published May 4, 2022 and initiated April 4, 2022. Recalling firm: Olympia Compounding Pharmacy dba Olympia Pharmacy; Status: Terminated; Lot: Lot: F41116 BUD: 6/16/2022,. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Reconstitution time

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Olympia Compounding Pharmacy dba Olympia Pharmacy
Distributor
Distributed Nationwide in the USA
Lot
Lot: F41116 BUD: 6/16/2022,
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was NAD+ Nicotinamide Adenine Dinucleotide Lyophilized powder for reconstitution, Multi-Dose 500 mg Per Vial, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0083-00 recalled?

Yes. FDA published recall D-0828-2022 on May 4, 2022. Reported hazard: Failed Reconstitution time

What should I do if I have this product?

Voluntary: Firm initiated · Letter